Corporate Profile

Webcast ImageWebcast
Teleflex Incorporated at Deutsche Bank Securities 41st Annual Health Care Conference (Replay)
05/04/16 at 11:20 a.m. ET
Teleflex Incorporated at Deutsche Bank Securities 41st Annual Health Care Conference
Wednesday, May 4, 2016 11:20 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Q1 2016 Teleflex Incorporated Earnings Conference Call (Replay)
04/28/16 at 8:00 a.m. ET
Q1 2016 Teleflex Incorporated Earnings Conference Call
Thursday, April 28, 2016 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. To achieve this mission, Teleflex is committed to the following: investing in technology and developing our pipeline; leveraging and building our core franchises and distribution channels; attracting, developing and retaining talented employees around the world; and continuing to build financial strength by expanding our margins and maintaining strong cash flow all in an effort to successfully grow our reputation as a solid investment and a profitable, strong employer. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Our products are used in a wide variety of markets and are not dependent upon any one end-market or procedure.

We are focused on achieving consistent , sustainable and profitable growth by increasing our market share and improving operating efficiencies through:

  • • the development of new products and product line extensions;

  • • the investment in new technologies and broadening their applications;

  • • the expansion of the use of existing products in existing markets, as well as in new geographic markets;

  • • leveraging our direct sales force and distribution network with new products, manufacturing and distribution facility rationalization and achieving economies of scale as we continue to expand; and

  • • the potential broadening of our product portfolio through select acquisitions, licensing arrangements and partnerships that enhance, extend or expedite our development initiatives or our ability to increase our market share.
 
Recent NewsMore »
05/24/16
Teleflex to Showcase Key Anaesthesia Products at Euroanaesthesia 2016 ("ESA") in London
WAYNE, Pa.--(BUSINESS WIRE)--May 24, 2016-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for Critical Care, Urology and Surgery, will showcase the new LMA® Protector™ and other key products in its striking Anaesthesia portfolio, together with its innovative Vascular Access platform, at the Euroanaesthesia Congress in London, UK on May 28 – 30, 2016. During ESA, Teleflex will focus on the new LMA® Protector™ Lary... 
05/18/16
Teleflex to Present at the 53rd European Renal, Dialysis and Transplant Congress (ERA-EDTA)
WAYNE, Pa.--(BUSINESS WIRE)--May 18, 2016-- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will showcase its range of interventional products at the 53rd European Renal, Dialysis and Transplant Congress in Vienna on May 21 - 24, 2016. During the event, Teleflex will showcase the ARROW-ClarkTM VectorFlowTM Hemodialysis Catheter. Designed for optimum performance, the AR... 
05/11/16
Teleflex Incorporated Announces Pricing of $400 Million Senior Notes Offering
WAYNE, Pa.--(BUSINESS WIRE)--May 11, 2016-- Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today that it priced its offering of $400.0 million aggregate principal amount of 4.875% senior notes due 2026 (the “Notes”) at an issue price of 100.000%. The sale of the Notes is expected to close on May 16, 2016, subject to customary closing conditions. The Notes will be guaranteed by each of Teleflex’s existing and future wholly-owned d... 
05/11/16
Teleflex Incorporated Announces Public Offering of $400 Million of Senior Notes
WAYNE, Pa.--(BUSINESS WIRE)--May 11, 2016-- Teleflex Incorporated (NYSE: TFX) (“Teleflex”) announced today the registered public offering, subject to market and other conditions, of $400.0 million aggregate principal amount of senior notes due 2026 (the “Notes”). The interest rate and other terms of the Notes will be determined at pricing. The Notes will be guaranteed by each of Teleflex’s existing and future wholly-owned domestic subsidia... 
 
Upcoming EventsMore »
There are currently no events scheduled.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.


Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet